Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


12>>>
26 Items
Title  Creator  Group name  Publishing year 
[Preventing the risks of interaction between cancer treatments and complementary care strategies] Ninot et al. EquipeAD 2024-11-15
Head and neck cancer patients treated with concomitant chemoradiotherapy involving the oral cavity and oropharynx: is another choice possible than prophylactic gastrostomy? Senesse et al. EquipeAD 2024-05-01
Trismus Occurrence and Link With Radiotherapy Doses in Head and Neck Cancer Patients Treated With Chemoradiotherapy Faravel et al. EquipeAD 2023
Response to Somay et al. Letter to the Editor Regarding "Trismus Occurrence and Link With Radiotherapy Doses in Head and Neck Cancer Patients Treated With Chemoradiotherapy" Faravel et al. EquipeAD 2023
Identification of 18F-FDG PET/CT Parameters Associated with Weight Loss in Patients with Esophageal Cancer Galvez et al. EquipeAD 2023-07-05
[Non-pharmalogical interventions and breast cancer: What benefit in addition to radiotherapy?] Lognos et al. EquipeJPP 2022-06
Reply to Caccialanza et al Boisselier et al. EquipeAD 2021-04-06
Importance of Patient Education for At-home Yoga Practice in Women With Hormonal Therapy-induced Pain During Adjuvant Breast Cancer Treatment: A Feasibility Study Faravel et al. EquipeCTCS 2021 Jan-Dec
Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis Martin et al. EquipeAD 2021-10
[Not Available] Lacroix et al. EquipeAD 2020
Exercise and cancer: Evidence of efficacy during and after treatments Ninot et al. EquipeAD 2020-04
Cancer-Associated Malnutrition and CT-Defined Sarcopenia and Myosteatosis Are Endemic in Overweight and Obese Patients Martin et al. EquipeAD 2020-02
Brief Hospital Supervision of Exercise and Diet During Adjuvant Breast Cancer Therapy Is Not Enough to Relieve Fatigue: A Multicenter Randomized Controlled Trial Jacot et al. EquipePC 2020-10-09
A double-blind phase III trial of immunomodulating nutritional formula during adjuvant chemoradiotherapy in head and neck cancer patients: IMPATOX Boisselier et al. EquipeAD Sep 16, 2020
Short- and long-term impact of adapted physical activity and diet counseling during adjuvant breast cancer therapy: the "APAD1" randomized controlled trial Carayol et al. EquipeCTCS Jul 25, 2019
Complementary and Alternative Medicine in Patients With Breast Cancer: Exploratory Study of Social Network Forum Data Lognos et al. EquipeAD Nov 27, 2019
Assessing dietary intake in accordance with guidelines: Useful correlations with an ingesta-Verbal/Visual Analogue Scale in medical oncology patients Guerdoux-Ninot et al. EquipeAD 2019-08
Artificial nutrition in patients with cancer has no impact on tumour glucose metabolism: Results of the PETANC Study Deshayes et al. EquipeAD Oct 2019
Patient-centeredness to anticipate and organize an end-of-life project for patients receiving at-home palliative care: a phenomenological study Oude Engberink et al. EquipeAD 2017-02-23
Management of Cancer Cachexia and Guidelines Implementation in a Comprehensive Cancer Center: A Physician-Led Cancer Nutrition Program Adapted to the Practices of a Country Senesse et al. EquipeAD 09 2017
Reproductive Decision-Making in MMR Mutation Carriers After Results Disclosure: Impact of Psychological Status in Childbearing Options Duffour et al. EquipeMY 06 2016
Meal context and food preferences in cancer patients: results from a French self-report survey Guerdoux-Ninot et al. EquipeAD 2016
Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens Ali et al. EquipeMY Apr 2016
A phase III study evaluating oral glutamine and transforming growth factor-beta 2 on chemotherapy-induced toxicity in patients with digestive neoplasm Khemissa et al. EquipeAD 2016-03
Feasibility and tolerability of self-insertion of a transnasal tube for esophagogastroduodenoscopy: a pilot study Senesse et al. EquipeAD 2015
12>>>
26 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés